@Milanese68 Ive sign up and sent my support for class action, and as previously stated will partially fund a class action, based on lack of disclosure over the 2015/2016 period.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%